Aldeyra Therapeutics Inc. (ALDX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aldeyra Therapeutics Inc.

    NASDAQ: ALDX · Real-Time Price · USD
    5.74
    0.42 (7.89%)
    At close: Oct 03, 2025, 3:59 PM
    5.62
    -2.09%
    After-hours: Oct 03, 2025, 07:56 PM EDT

    Aldeyra Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 249.62K 262.78K 258.71K 264.18K
    Gross Profit
    		 -249.62K -262.78K -258.71K -264.18K
    Operating Income
    		 -60.12M -42.79M -62.68M -56.22M
    Interest Income
    		 6.19M 7.32M 2.35M 185.36K
    Pretax Income
    		 -55.85M -37.54M -62.02M -57.78M
    Net Income
    		 -55.85M -37.54M -62.02M -57.78M
    Selling & General & Admin
    		 11.89M 13.34M 15.37M 11.28M
    Research & Development
    		 48.23M 29.46M 47.31M 44.94M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 60.12M 42.79M 62.68M 56.22M
    Interest Expense
    		 1.93M 2.07M 1.69M 1.74M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 60.12M 42.79M 62.68M 56.22M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 59.48M 58.94M 58.41M 54.04M
    Shares Outstanding (Diluted)
    		 59.48M 58.94M 58.41M 54.04M
    EPS (Basic)
    		 -0.94 -0.64 -1.06 -1.07
    EPS (Diluted)
    		 -0.94 -0.64 -1.06 -1.07
    EBITDA
    		 -53.68M -35.21M -60.07M -55.77M
    EBIT
    		 -53.93M -35.47M -60.33M -56.03M
    Depreciation & Amortization
    		 249.62K 262.78K 258.71K 264.18K

    Add to Watchlist